Table of Contents:
  • How should we move the field of chemopreventive agent development forward in a productive manner? / Frank Louis Meyskens, Eva Szabo
  • The problem with risk selection: scientific and psychosocial aspects / Anne-Renée Hartman
  • Chemoprevention of lung cancer / Stéphane Vignot ... [et al.]
  • Anti-nicotine vaccination: where are we? / T. Cerny
  • Primary prevention of colorectal cancer: lifestyle, nutrition, exercise / María Elena Martínez
  • Chemoprevention of colorectal cancer: ready for routine use? / Nadir Arber, Bernard Levin
  • Screening of colorectal cancer: progress and problems / Sidney J. Winawer
  • The role of endogenous hormones in the etiology and prevention of breast cancer: the epidemiological evidence / Paola Muti
  • Innovative agents in cancer prevention / Margaret M. Manson ... [et al.]
  • The IARC commitment to cancer prevention: the example of papillomavirus and cervical cancer / Silvia Franceschi
  • Health economics in the genomic age / Thomas D. Szucs
  • Screening for cancer: are resources being used wisely? / Robert M. Kaplan.
  • Lifestyle and medical approaches to cancer prevention / Peter Greenwald
  • Application of genetics to the prevention of colorectal cancer / John L. Hopper
  • Genetics and prevention of oesophageal adenocarcinoma / Rebecca C. Fitzgerald
  • Preclinical models relevant to diet, exercise, and cancer risk / R. James Barnard, William J. Aronson
  • Individualizing interventions for cancer prevention / Michael Pollak
  • Can animal models help us select specific compounds for cancer prevention trials? / Ernest T. Hawk ... [et al.]
  • Problems with using biomarkers as surrogate end points for cancer: a cautionary tale / Arthur Schatzkin
  • Can a marker be a surrogate for development of cancer, and would we know it if it exists? / William B. Armstron, Thomas H. Taylor, Frank L. Meyskens